Xiongwei Deng

2.3k total citations · 1 hit paper
56 papers, 1.9k citations indexed

About

Xiongwei Deng is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Xiongwei Deng has authored 56 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 21 papers in Biomedical Engineering and 11 papers in Biomaterials. Recurrent topics in Xiongwei Deng's work include Nanoplatforms for cancer theranostics (18 papers), Nanoparticle-Based Drug Delivery (10 papers) and RNA Interference and Gene Delivery (9 papers). Xiongwei Deng is often cited by papers focused on Nanoplatforms for cancer theranostics (18 papers), Nanoparticle-Based Drug Delivery (10 papers) and RNA Interference and Gene Delivery (9 papers). Xiongwei Deng collaborates with scholars based in China, United States and Germany. Xiongwei Deng's co-authors include Yan Wu, Jianqing Lu, Leihou Shao, Wang Sheng, Xiangqian Xiao, Caiyan Zhao, Yi Zeng, Zhaoxia Yin, Kelei Hu and Minjun Cao and has published in prestigious journals such as Advanced Materials, Biomaterials and Chemical Communications.

In The Last Decade

Xiongwei Deng

53 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

2014 443 citations Xiongwei Deng, Minjun Cao et al. Biomaterials profile →

Peers

Countries citing papers authored by Xiongwei Deng

Since Specialization

Citations

This map shows the geographic impact of Xiongwei Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiongwei Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiongwei Deng more than expected).

Fields of papers citing papers by Xiongwei Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiongwei Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiongwei Deng. The network helps show where Xiongwei Deng may publish in the future.

Co-authorship network of co-authors of Xiongwei Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiongwei Deng. A scholar is included among the top collaborators of Xiongwei Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiongwei Deng. Xiongwei Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Epimedin B attenuates ovariectomy-induced bone loss by suppressing osteoclastogenesis through decreasing ROS production and targeting ESR1 2025 ·Free Radical Biology and Medicine ·(unknown), (unknown), (unknown), Huiting Chen, (unknown), Guo‐ye Mo, Yongxian Li, Qiang Li, Xiongwei Deng, (unknown), Peng Gu	1
2	Topological cues of microparticles train stem cells for tissue repair via mechanotransduction 2025 ·Bioactive Materials ·Jiannan Mao, Yichang Xu, Wenbo Wang, Xiongwei Deng, (unknown), (unknown), Jincheng Tang, Wei Wang, (unknown), Liang Wu, Kun Xi, (unknown), Yong Gu, Liang Chen	1
3	Galangin Promotes Tendon Repair Mediated by Tendon-Derived Stem Cells through Activating the TGF-β1/Smad3 Signaling Pathway 2024 ·Chemical and Pharmaceutical Bulletin ·Xiongwei Deng, (unknown), Haitao Yuan, (unknown), (unknown)	2
4	Sequential-delivery nanocomplex for combined anti-angiogenesis and gene therapy against colorectal cancer 2023 ·International Journal of Pharmaceutics ·Fan Jia, Yunhao Li, Yujuan Gao, Xuan Wang, Jianqing Lu, Xinyue Cui, Zian Pan, (unknown), Xiongwei Deng, Yan Wu	6
5	Reactive Oxygen-Primed and Autophagy Inhibition-Sensitized Ferroptosis Combined with Photothermal Ablation for Tumor Therapy 2023 ·ACS Materials Letters ·Dihai Gu, (unknown), Hongshuai Wu, Jiannan Mao, Jinzhong Hu, Xu Zhi, (unknown), (unknown), Xiongwei Deng, Yihong Wang	14
6	Fluorescence‐Amplified Origami Microneedle Device for Quantitatively Monitoring Blood Glucose (Adv. Mater. 29/2023) 2023 ·Advanced Materials ·Xianlei Li, Xuehui Xu, KeWei Wang, Yuqiu Chen, (unknown), (unknown), Zian Pan, Fan Jia, (unknown), Xuan Wang, Xiongwei Deng, Yi Zhao, (unknown), Qiao Jiang, Baoquan Ding, Yan Wu, Ran Liu	2
7	CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach 2023 ·Journal of Nanobiotechnology ·Xiaofei Zhang, Qin Hu, (unknown), Xinyue Cui, (unknown), Li Wang, Xiongwei Deng, Ze Zhang, Sheng Wang, (unknown)	12
8	Coordinated modulation of long non-coding RNA ASBEL and curcumin co-delivery through multicomponent nanocomplexes for synchronous triple-negative breast cancer theranostics 2023 ·Journal of Nanobiotechnology ·(unknown), Fengjuan Lin, (unknown), Yang Xia, (unknown), Xiangqian Xiao, Qin Hu, Xiongwei Deng, Qun Li, Sheng Wang	3
9	Research progress on the fibrinolytic enzymes produced from traditional fermented foods 2023 ·Food Science & Nutrition ·(unknown), (unknown), Xiaomei Xie, Xiongwei Deng, (unknown)	4
10	Self-assembled fluorescent hybrid nanoparticles-mediated collaborative lncRNA CCAT1 silencing and curcumin delivery for synchronous colorectal cancer theranostics 2021 ·Journal of Nanobiotechnology ·Jia Fan, Yunhao Li, Xiongwei Deng, Xuan Wang, Xinyue Cui, Jianqing Lu, Zian Pan, Yan Wu	26
11	Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy 2021 ·International Journal of Pharmaceutics ·(unknown), Xinyue Cui, Liqun Yang, Qin Hu, Danyang Li, Xiaofei Zhang, Lu Han, (unknown), (unknown), (unknown), Qi Ju, Xiongwei Deng, Yan Wu, Sheng Wang	27
12	Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles 2020 ·Nature Biomedical Engineering ·Suping Li, Yinlong Zhang, Shih‐Hsin Ho, Bozhao Li, Meifang Wang, Xiongwei Deng, Na Yang, Guangna Liu, Zefang Lu, Junchao Xu, Quanwei Shi, (unknown), Lirong Zhang, Yan Wu, Yuliang Zhao, Guangjun Nie	124
13	Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and in vivo photoacoustic imaging 2020 ·Theranostics ·Leihou Shao, Yunhao Li, Feifei Huang, Xuan Wang, Jianqing Lu, Fan Jia, Zian Pan, Xinyue Cui, Guanglu Ge, Xiongwei Deng, Yan Wu	93
14	Self-assembled nanovehicle-mediated co-encapsulation of inactivated EV71 virus and CpG oligonucleotides elicits potent anti-EV71 humoral and cellular immune protective responses 2019 ·Biochemical and Biophysical Research Communications ·Liang Hao, Xiangqian Xiao, Xiaofei Zhang, Qin Hu, Yishu Yang, Shan Cen, Xiongwei Deng, Wang Sheng	3
15	Inhibition of protein kinase C activity inhibits osteosarcoma metastasis 2018 ·Archives of Medical Science ·(unknown), Xiongwei Deng, (unknown), (unknown), Chao Xue	4
16	Improving the activity of the subtilisin nattokinase by site-directed mutagenesis and molecular dynamics simulation 2015 ·Biochemical and Biophysical Research Communications ·(unknown), Xiongwei Deng, Wei Bao, Li Zhu, (unknown), (unknown), Yan Jia, Zhongliang Zheng, Guolin Zou	32
17	Smart micelle@polydopamine core–shell nanoparticles for highly effective chemo–photothermal combination therapy 2015 ·Nanoscale ·Ruirui Zhang, Shishuai Su, Kelei Hu, Leihou Shao, Xiongwei Deng, Wang Sheng, Yan Wu	97
18	Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma 2015 ·Cancer Biology & Therapy ·(unknown), (unknown), (unknown), Feng Zhou, Xiongwei Deng, (unknown)	36
19	Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer breakdown → 2014 ·Biomaterials ·Xiongwei Deng, Minjun Cao, Jiakun Zhang, Kelei Hu, Zhaoxia Yin, Zhixiang Zhou, Xiangqian Xiao, Yishu Yang, Wang Sheng, Yan Wu, Yi Zeng	443
20	Protamine sulfate–nanodiamond hybrid nanoparticles as a vector for MiR-203 restoration in esophageal carcinoma cells 2013 ·Nanoscale ·Minjun Cao, Xiongwei Deng, Shishuai Su, Fang Zhang, Xiangqian Xiao, Qin Hu, (unknown), Burton B. Yang, Yan Wu, Wang Sheng, Yi Zeng	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact